Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Anti-cancer and Anti-proliferative Activity of Medicinal Plant Extracts (Saffron, Green Tea, Clove, Fenugreek) on Toll Like Receptors Pathway

  • Ajmal, Sidra (Department of Chemistry and Biochemistry, University of Oklahoma) ;
  • Shafqat, Mahwish (Department of Biochemistry, Kinnaird College for Women) ;
  • Ajmal, Laiba (Department of Chemistry and Biochemistry, University of Oklahoma) ;
  • Younas, Hooria (Department of Biochemistry, Kinnaird College for Women) ;
  • Tasadduq, Raazia (Department of Biochemistry, Kinnaird College for Women) ;
  • Mahmood, Nasir (Department of Biochemistry, Human Genetics and Molecular Biology, University of Health Sciences (UHS), Lahore, Pakistan & Department of Cell and System Biology, University of Toronto)
  • Received : 2022.01.08
  • Accepted : 2022.08.16
  • Published : 2022.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Despite considerable efforts, cancer remains an aggressive killer worldwide. Chemotherapeutic drugs that are currently in use lead to destructive side effects and have not succeeded in fulfilling expectations. For centuries, medicinal plants are used for treating various diseases and are also known to have anticancer activity. The main aim of this research was to evaluate antiproliferative activity of saffron, clove, fenugreek, and green tea on Vero and MDA-MB-231 cell lines and to subsequently analyze the effect of these extracts on IRAK-4, TAK1, IKK-alpha, IKK-beta, NF-Kappa B, IRF3, IRF7 genes in Toll Like Receptors (TLRs) pathway. Antiproliferative assay was done by Neutral Red Dye uptake assay. Methanolic extract of green tea was found to be most effective against both cell lines as IC50 was achieved at least concentration of the extract. For molecular studies, MDAMB-231 cells were sensitized with methanolic extract of green tea at same IC50, and RT-PCR was performed to determine the relative expression of genes. Expression of IRAK-4, TAK1, IKK-beta, NF-Kappa B, IRF3 genes was down regulated and IRF7 and IKKalpha was upregulated. Green tea has a potential cytotoxic effect on both cell lines which was demonstrated by its effect on the expression of (TLRs) pathway genes.

Keywords

References

  1. Baskar, R.; Lee, K. A.; Yeo, R.; Yeoh, K. W. Int. J. Med. Sci. 2012, 9, 193-199. https://doi.org/10.7150/ijms.3635
  2. Housman, G.; Byler, S.; Heerboth, S.; Lapinska, K.; Longacre, M.; Snyder, N.; Sarkar, S. Cancers 2014, 6, 1769-1792. https://doi.org/10.3390/cancers6031769
  3. Weber, G. F. Mol. Ther. Cancer 2014, 2014, 9-112.
  4. Zajaczkowska, R.; Kocot-Kepska, M.; Leppert, W.; Wrzosek, A.; Mika, J.; Wordliczek, J. Int. J. Mol. Sci. 2019, 20, 1451. https://doi.org/10.3390/ijms20061451
  5. Grisold, W.; Cavaletti, G.; Windebank, A. J. Neuro. Oncol. 2012, 14, iv45-iv54.
  6. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Pharmacogn Rev. 2010, 4, 118-126. https://doi.org/10.4103/0973-7847.70902
  7. Dasari, S.; Tchounwou, B. P. Eur. J. Pharmacol. 2014, 740, 364-378. https://doi.org/10.1016/j.ejphar.2014.07.025
  8. Malcolm R Alison. Encyclopedia of life sciences: Cancer; Nature Publishing Group: London, 2001, pp 1-8.
  9. Patra, S.; Nay ak, R.; Patro, S.; Pradhan, B.; Sahu, B.; Behera, C.; Bhutia, S. K.; Jena, M. Biotechnol. Rep (Amst). 2021, 30, e00633.
  10. Kieliszek, M.; Edris, A.; Kot, A. M.; Piwowarek, K. Molecules 2020, 25, 2478. https://doi.org/10.3390/molecules25112478
  11. Mahmood, N.; Younas, H.; Zafar, M.; Shahid, S.; Ajmal, S.; Qursehi, Z.; Nasir, S. B. Nucleosides Nucleotides Nucleic Acids. 2021, 40, 434-469. https://doi.org/10.1080/15257770.2021.1896000
  12. O'Neill, L. A. J.; Golenbock, D.; Bowie, A. G. Nat. Rev. Immunol. 2013, 13, 453-460. https://doi.org/10.1038/nri3446
  13. Li, F.; Wang, F.; Yu, F.; Fang, Y.; Xin, Z.; Yang, F.; Xu, J.; Zhao, L.; Hu, Q. Food Chem. 2008, 111, 165-170. https://doi.org/10.1016/j.foodchem.2008.03.057
  14. Dwivedi, V.; Shrivastava, R.; Hussain, S.; Ganguly, C.; Bharadwaj, M. Asian Pac. J. Cancer Prev. 2011, 12, 1989-1993.
  15. Abd El Azim, M. H. M.; EI-Mesallamy, A. M. D.; EI-Gerby, M.; Awad, A. J. Microb. Biochem. Technol. 2014, 10, s8-s007.
  16. Khalil, M. I.; Tanvir, E. M.; Afroz, R.; Sulaiman, S. A.; Gan, S. H. Biomed. Res. Int. 2015, 2015, 286051.
  17. Bajbouj, K.; Schulze-Luehrmann, J.; Diermeier, S.; Amin, A.; Schneider-Stock, R. BMC Complement. Altern. Med. 2012, 12, 69.
  18. Karin, M. Cold Spring Harb Perspect Biol. 2009, 1, a000141.
  19. Hoesel, B.; Schmid, J. A. Mol. Cancer 2013, 12, 86.
  20. Rhyasen, G. W.; Starczynowski, D. T. Br. J. Cancer 2015, 112, 232-237. https://doi.org/10.1038/bjc.2014.513
  21. Roh, Y. S.; Song, J.; Seki, E. Br. J. Cancer 2014, 49, 185-194.
  22. Bidwell, B. N.; Slaney, C. Y.; Withana, N. P.; Forster, S.; Cao, Y.; Loi, S.; Andrews, D.; Mikeska, T.; Mangan, N. E.; Samarajiwa, S. A.; de Weerd, N. A.; Gould, J.; Argani, P.; Moller, A.; Smyth, M. J.; Anderson, R. L.; Hertzog, P. J.; Parker, B. S. Nat. Med. 2012, 18, 1224-1231. https://doi.org/10.1038/nm.2830
  23. Ning, S.; Pagano, J. S.; Barber, G. N. Genes Immun. 2011, 12, 399-414.